<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Intensive Care Med Exp</journal-id><journal-id journal-id-type="iso-abbrev">Intensive Care Med Exp</journal-id><journal-title-group><journal-title>Intensive Care Medicine Experimental</journal-title></journal-title-group><issn pub-type="epub">2197-425X</issn><publisher><publisher-name>Springer International Publishing</publisher-name><publisher-loc>Cham</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">26215810</article-id><article-id pub-id-type="pmc">4513008</article-id><article-id pub-id-type="publisher-id">46</article-id><article-id pub-id-type="doi">10.1186/s40635-015-0046-1</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research</subject></subj-group></article-categories><title-group><article-title>Effects of norepinephrine on tissue perfusion in a sheep model of intra-abdominal hypertension</article-title></title-group><contrib-group><contrib contrib-type="author" equal-contrib="yes"><name><surname>Ferrara</surname><given-names>Gonzalo</given-names></name><address><email>gonzaloferrara@gmail.com</email></address><xref ref-type="aff" rid="Aff1"/><xref ref-type="aff" rid="Aff2"/></contrib><contrib contrib-type="author" equal-contrib="yes"><name><surname>Kanoore Edul</surname><given-names>Vanina S</given-names></name><address><email>vaninaedul@gmail.com</email></address><xref ref-type="aff" rid="Aff1"/><xref ref-type="aff" rid="Aff2"/></contrib><contrib contrib-type="author"><name><surname>Caminos Eguillor</surname><given-names>Juan F</given-names></name><address><email>peguillor@hotmail.com</email></address><xref ref-type="aff" rid="Aff2"/></contrib><contrib contrib-type="author"><name><surname>Martins</surname><given-names>Enrique</given-names></name><address><email>enriqueflmartins@gmail.com</email></address><xref ref-type="aff" rid="Aff2"/></contrib><contrib contrib-type="author"><name><surname>Canull&#x000e1;n</surname><given-names>Carlos</given-names></name><address><email>carloscanullan@yahoo.com.ar</email></address><xref ref-type="aff" rid="Aff2"/></contrib><contrib contrib-type="author"><name><surname>Canales</surname><given-names>H&#x000e9;ctor S</given-names></name><address><email>canales_hector@speedy.com.ar</email></address><xref ref-type="aff" rid="Aff2"/></contrib><contrib contrib-type="author"><name><surname>Ince</surname><given-names>Can</given-names></name><address><email>c.ince@amc.uva.nl</email></address><xref ref-type="aff" rid="Aff1"/></contrib><contrib contrib-type="author"><name><surname>Estenssoro</surname><given-names>Elisa</given-names></name><address><email>estenssoro.elisa@gmail.com</email></address><xref ref-type="aff" rid="Aff2"/></contrib><contrib contrib-type="author" corresp="yes"><name><surname>Dubin</surname><given-names>Arnaldo</given-names></name><address><email>arnaldodubin@gmail.com</email></address><xref ref-type="aff" rid="Aff1"/></contrib><aff id="Aff1"><label/>Academic Medical Center, Department of Translational Physiology, University of Amsterdam, Meibergdreef 9, 1105 Amsterdam, AZ The Netherlands </aff><aff id="Aff2"><label/>C&#x000e1;tedra de Farmacolog&#x000ed;a Aplicada, Facultad de Ciencias M&#x000e9;dicas, Universidad Nacional de La Plata, 60 y 120, 1900 La Plata, Argentina </aff></contrib-group><pub-date pub-type="epub"><day>31</day><month>3</month><year>2015</year></pub-date><pub-date pub-type="pmc-release"><day>31</day><month>3</month><year>2015</year></pub-date><pub-date pub-type="collection"><month>12</month><year>2015</year></pub-date><volume>3</volume><elocation-id>11</elocation-id><history><date date-type="received"><day>14</day><month>10</month><year>2014</year></date><date date-type="accepted"><day>12</day><month>2</month><year>2015</year></date></history><permissions><copyright-statement>&#x000a9; Ferrara et al.; licensee Springer. 2015</copyright-statement><license license-type="open-access"><license-p>This is an Open Access article distributed under the terms of the Creative Commons Attribution License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0">http://creativecommons.org/licenses/by/4.0</ext-link>), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited.</license-p></license></permissions><abstract id="Abs1"><sec><title>Background</title><p>The aim of the study was to describe the effects of intra-abdominal hypertension (IAH) on regional and microcirculatory intestinal blood flow, renal blood flow, and urine output, as well as their response to increases in blood pressure induced by norepinephrine.</p></sec><sec><title>Methods</title><p>This was a pilot, controlled study, performed in an animal research laboratory. Twenty-four anesthetized and mechanically ventilated sheep were studied. We measured systemic hemodynamics, superior mesenteric and renal blood flow, villi microcirculation, intramucosal-arterial PCO<sub>2</sub>, urine output, and intra-abdominal pressure. IAH (20&#x000a0;mm Hg) was generated by intraperitoneal instillation of warmed saline. After 1&#x000a0;h of IAH, sheep were randomized to IAH control (<italic>n</italic>&#x02009;=&#x02009;8) or IAH norepinephrine (<italic>n</italic>&#x02009;=&#x02009;8) groups, for 1&#x000a0;h. In this last group, mean arterial pressure was increased about 20&#x000a0;mm Hg with norepinephrine. A sham group (<italic>n</italic>&#x02009;=&#x02009;8) was also studied. Fluids were administered to prevent decreases in cardiac output. Differences between groups were analyzed with two-way repeated measures of analysis of variance (ANOVA).</p></sec><sec><title>Results</title><p>After 2&#x000a0;h of IAH, abdominal perfusion pressure decreased in IAH control group compared to IAH norepinephrine and sham groups (49&#x02009;&#x000b1;&#x02009;11, 73&#x02009;&#x000b1;&#x02009;11, and 86&#x02009;&#x000b1;&#x02009;15&#x000a0;mm Hg, <italic>P</italic> &#x0003c; 0.0001). There were no differences in superior mesenteric artery blood flow, intramucosal-arterial PCO<sub>2</sub>, and villi microcirculation among groups. Renal blood flow (49&#x02009;&#x000b1;&#x02009;30, 32&#x02009;&#x000b1;&#x02009;24, and 102&#x02009;&#x000b1;&#x02009;45&#x000a0;mL.min<sup>&#x02212;1</sup>.kg<sup>&#x02212;1</sup>, <italic>P</italic> &#x0003c; 0.0001) and urinary output (0.3&#x02009;&#x000b1;&#x02009;0.1, 0.2&#x02009;&#x000b1;&#x02009;0.2, and 1.0&#x02009;&#x000b1;&#x02009;0.6&#x000a0;mL.h<sup>&#x02212;1</sup>.kg<sup>&#x02212;1</sup>, <italic>P</italic> &#x0003c; 0.0001) were decreased in IAH control and IAH norepinephrine groups, compared to the sham group.</p></sec><sec><title>Conclusions</title><p>In this experimental model of IAH, the gut and the kidney had contrasting responses: While intestinal blood flow and villi microcirculation remained unchanged, renal perfusion and urine output were severely compromised.</p></sec><sec><title>Electronic supplementary material</title><p>The online version of this article (doi:10.1186/s40635-015-0046-1) contains supplementary material, which is available to authorized users.</p></sec></abstract><kwd-group xml:lang="en"><title>Keywords</title><kwd>Intra-abdominal hypertension</kwd><kwd>Perfusion pressure</kwd><kwd>Microcirculation</kwd><kwd>Renal blood flow</kwd><kwd>Urinary output</kwd></kwd-group><custom-meta-group><custom-meta><meta-name>issue-copyright-statement</meta-name><meta-value>&#x000a9; The Author(s) 2015</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="Sec1"><title>Background</title><p>The occurrence of elevated intra-abdominal pressure (IAP) has been increasingly recognized in critically ill patients as a complication of several abdominal and extra-abdominal conditions and also as an independent predictor of mortality [<xref ref-type="bibr" rid="CR1">1</xref>]. Sustained or repeated values of IAP &#x02265;12&#x000a0;mm Hg define intra-abdominal hypertension (IAH). IAH may affect organ function and lead to the abdominal compartment syndrome, which is characterized by a sustained IAP &#x0003e;20&#x000a0;mm Hg plus the development of new organ dysfunctions/failures [<xref ref-type="bibr" rid="CR2">2</xref>].</p><p>The involvement of intra-abdominal organs during IAH is heterogeneous. Clinical and experimental studies showed that the kidney is particularly susceptible<bold>,</bold> even to small increases in IAP [<xref ref-type="bibr" rid="CR3">3</xref>], evidenced by decreased glomerular filtration and oliguria. In contrast, the gut compromise in patients with IAH seems to be variable: reports go from overt ischemia with bowel infarction [<xref ref-type="bibr" rid="CR4">4</xref>], to subtle hypoperfusion generating mucosal barrier dysfunction [<xref ref-type="bibr" rid="CR5">5</xref>] or intramucosal acidosis [<xref ref-type="bibr" rid="CR6">6</xref>]. Experimental research also showed dissimilar gut alterations. Some studies found severe reductions in gut perfusion induced by an IAP of 15&#x000a0;mm Hg maintained for 2&#x000a0;h [<xref ref-type="bibr" rid="CR7">7</xref>], while others showed preservation of intestinal blood flow after 3&#x000a0;h of 20&#x000a0;mm Hg [<xref ref-type="bibr" rid="CR8">8</xref>]. These contradictory findings might be related to different models of IAH but also to the particular behavior of cardiac output in each animal model. Therefore, the decrease in regional and tissue intestinal blood flow might not be completely dissociated from the alterations in systemic hemodynamics.</p><p>The abdominal perfusion pressure (APP) is the difference between mean arterial pressure (MAP) and IAP. The APP is a surrogate of the driving pressure for the perfusion of intra-abdominal organs; and its decrease might thus be the major pathophysiologic mechanism underlying regional hypoperfusion and organ failures. The APP was suggested as a more accurate predictor of visceral perfusion and a better goal of resuscitation than isolated values of IAP or MAP [<xref ref-type="bibr" rid="CR9">9</xref>]; yet, there is no clinical evidence supporting an APP above 60&#x000a0;mm Hg as a therapeutic goal. Accordingly, the World Society for Abdominal Compartment Syndrome makes no recommendation regarding the use of APP in the resuscitation of critically ill patients with IAH [<xref ref-type="bibr" rid="CR10">10</xref>].</p><p>Few experimental studies have evaluated the benefits of increasing MAP on tissue perfusion. Hence, our goal was to describe the effects of IAH on regional and microvascular intestinal perfusion, and on renal blood flow and urinary output, in an adequately resuscitated sheep model. Another aim was to assess the effect of an increase in APP, mediated by norepinephrine.</p><p>Our hypothesis was that the IAH produces a heterogeneous compromise in the circulation of intra-abdominal organs and that norepinephrine restores such disorders.</p></sec><sec id="Sec2" sec-type="methods"><title>Methods</title><p>This study was approved by the local Animal Research Committee [0800-009634/11-000]. Care of animals was in accordance with National Institutes of Health (United States).</p><sec id="Sec3"><title>Surgical preparation</title><p>Twenty-four sheep (mean weight, 21&#x000a0;kg (SD, 4&#x000a0;kg)) were anesthetized with 30&#x000a0;mg.kg<sup>&#x02212;1</sup> of sodium pentobarbital, intubated, and mechanically ventilated with a Servo Ventilator 900C (Siemens-Elema AB, Solna, Sweden) with a tidal volume of 15&#x000a0;mL.kg<sup>&#x02212;1</sup>, an FiO<sub>2</sub> of 0.21, and a positive end-expiratory pressure of 6&#x000a0;cm H<sub>2</sub>O. The initial respiratory rate was set to keep the arterial PCO<sub>2</sub> between 35 and 40&#x000a0;mm Hg. This respiratory setting was maintained during the rest of the experiment. Neuromuscular blockade was performed with pancuronium bromide (0.06&#x000a0;mg.kg<sup>&#x02212;1</sup>). Additional pentobarbital boluses (1&#x000a0;mg.kg<sup>&#x02212;1</sup>) were administered hourly and when clinical signs of inadequate depth of anesthesia were evident. Analgesia was provided by fentanyl as a bolus of 2&#x000a0;&#x003bc;g.kg<sup>&#x02212;1</sup>, followed by 1&#x000a0;&#x003bc;g.h<sup>&#x02212;1</sup>.kg<sup>&#x02212;1</sup>. These drugs were intravenously administered.</p><p>A 7.5 French Swan-Ganz Standard Thermodilution Pulmonary Artery Catheter (Edwards Life Sciences, Irvine, CA, USA) was inserted through an introducer in the right external jugular vein; its side port was used to administer fluids and drugs. A catheter was placed in the descending aorta via the left femoral artery to measure blood pressure and obtain blood samples.</p><p>A midline laparotomy was performed, followed by a gastrostomy to drain gastric contents, and a splenectomy to avoid spleen contraction.</p><p>Perivascular ultrasonic flow probes were placed around the superior mesenteric artery and the left renal artery, to measure intestinal and renal arterial blood flows.</p><p>A catheter was situated in the superior mesenteric vein through a small vein proximal to the gut to draw blood samples. A tonometer was inserted through a small ileotomy to measure intramucosal PCO<sub>2</sub>.</p><p>IAP was measured through a saline-filled catheter positioned in the abdomen, and a tube was left in the left flank for intraperitoneal infusion of saline solution. An ileostomy was constructed on the right flank to allow the mucosa examination. Urinary output was monitored through a catheter inserted into the bladder. Finally, after complete hemostasis, the abdominal wall incision was hermetically closed.</p></sec><sec id="Sec4"><title>Measurements and derived calculations</title><p>Arterial, systemic, pulmonary, and central venous pressures and IAP were measured at end-expiration with zero set at the midaxillary line (Statham P23 AA, Statham, Hato Rey, Puerto Rico). Cardiac output was measured by thermodilution with 5&#x000a0;mL of 0&#x000b0;C saline solution (HP OmniCare Model 24 A 10, Hewlett Packard, Andover, Mass, USA). The mean value from three measurements taken randomly during the respiratory cycle was subsequently expressed per kilogram of body weight. Superior mesenteric and left renal blood flows were measured by an ultrasonic flowmeter (One Channel Perivascular Flowmeter, Transonics Systems Inc., Ithaca, NY, USA) and normalized to the organ weights.</p><p>Urinary output was monitored hourly and indexed to body weight. APP was calculated as MAP - IAP and renal filtration gradient (RFG) as MAP - 2 X IAP [<xref ref-type="bibr" rid="CR11">11</xref>].</p><p>Arterial, mixed venous, and mesenteric venous PO<sub>2</sub>, PCO<sub>2</sub>, and pH were measured with an ABL5 blood gas analyzer (Radiometer, Copenhagen, Denmark), and hemoglobin and oxygen saturation with an OSM3 cooximeter calibrated for sheep blood (Radiometer). Systemic and intestinal oxygen transports and consumptions (DO<sub>2</sub> and VO<sub>2</sub>) were calculated by standard equations and are expressed as indices of body and intestinal weight.</p><p>Intramucosal PCO<sub>2</sub> was measured with a tonometer (Tonometrics Catheter, Datex-Ohmeda, Helsinki, Finland) through the use of an automated air tonometry system (Tonocap, Datex-Ohmeda, Helsinki, Finland). Its value was used to calculate intramucosal-arterial PCO<sub>2</sub> (&#x00394;PCO<sub>2</sub>).</p><p>Arterial lactate, [Na<sup>+</sup>], [K<sup>+</sup>], and [Cl<sup>&#x02212;</sup>] were measured with a point-of-care analyzer (Stat Profile Critical Care Xpress, Nova Biomedical, Waltham, MA, USA). Anion gap was calculated as ([Na<sup>+</sup>]&#x02009;+&#x02009;[K<sup>+</sup>]) &#x02013; ([Cl<sup>&#x02212;</sup>]&#x02009;+&#x02009;[HCO<sub>3</sub><sup>&#x02212;</sup>]).</p></sec><sec id="Sec5"><title>Microcirculatory measurements and analysis</title><p>We evaluated the microcirculatory network in the sublingual and intestinal ileal mucosae with a MicroScan sidestream dark field (SDF) imaging device (MicroVision Medical, Amsterdam, Netherlands) [<xref ref-type="bibr" rid="CR12">12</xref>]. For the assessment of villi, the device was gently introduced into the abdomen through the ileostomy. Careful precautions and specific steps were taken both to obtain images of adequate quality and to ensure good reproducibility. Experienced researchers performed the video acquisitions and image analyses. Steady images of at least 20&#x000a0;s were obtained to avoid pressure artifacts, by means of a portable computer and an ADVC110 analog-to-digital video converser (Canopus Co, San Jose, CA, USA). Clips were stored as AVI files on the hard disk to allow computerized frame-by-frame image analysis. SDF images were acquired from three different regions in the site of interest, after verifying that focus and contrast adjustment were adequate; poor-quality images were discarded. The whole sequence was used to characterize the microvascular blood flow semi-quantitatively, especially regarding the presence of stopped or intermittent flow.</p><p>The video clips were analyzed blindly and randomly. First, we used a modification of a semi-quantitative score, which distinguishes no flow (0), intermittent flow (1), sluggish flow (2), and continuous flow (3). A value was assigned to each individual vessel. The overall score, called the microvascular flow index (MFI), is the mean of the individual vessel values. For each animal, values obtained from three fields were averaged [<xref ref-type="bibr" rid="CR13">13</xref>]. Second, we used Automated Vascular Analysis (AVA) 3.0, an image analysis software package (Academic Medical Center, University of Amsterdam, Amsterdam, Netherlands) developed for SDF video images, to determine vascular density [<xref ref-type="bibr" rid="CR14">14</xref>]. Finally, we estimated the percentage of perfused vessels and the total and perfused vascular densities. The former was calculated from the number of vessels with flows of 2 and 3 after division by the total number of vessels and multiplication by 100. The latter was calculated from the total density, after multiplication by the fraction of perfused vessels. We also determined the heterogeneity of perfusion as the heterogeneity flow index, as the difference between the highest and lowest MFI, divided by the mean MFI [<xref ref-type="bibr" rid="CR15">15</xref>].</p><p>In the sheep, most of sublingual vascular density (97% (SD, 1%) of total vessel length, and all villi vessels, consist of small vessels (diameter below 20&#x000a0;&#x003bc;m)) [<xref ref-type="bibr" rid="CR16">16</xref>], so the analysis was focused on these type of vessels.</p></sec><sec id="Sec6"><title>Experimental procedure</title><p>Basal measurements were taken after a stabilization period of no less than 30&#x000a0;min. Then, warmed saline solution (363&#x02009;&#x000b1;&#x02009;47&#x000a0;mL.kg<sup>&#x02212;1</sup> of body weight) was infused to reach an IAP of 20&#x000a0;mm Hg. IAP was continuously monitored and maintained constant. After 1&#x000a0;h of IAH, sheep were randomized to IAH control (<italic>n</italic>&#x02009;=&#x02009;8) or IAH norepinephrine (<italic>n</italic>&#x02009;=&#x02009;8) groups. In both groups, IAP was maintained for 1 additional hour at 20&#x000a0;mm Hg; but in the second one, MAP was increased about 20&#x000a0;mm Hg by means of norepinephrine to reach APP &#x0003e;60&#x000a0;mm Hg. We also included a sham group (<italic>n</italic>&#x02009;=&#x02009;8) in which all surgical procedures were performed without infusing intraperitoneal saline solution. An infusion of hydroxyethyl starch 6% 130/0.4 in 0.9% NaCl (Voluven, Fresenius Kabi, Bad Homburg, Germany) was administered throughout the study to maintain the cardiac output constant and to avoid MAPs &#x0003c;60&#x000a0;mm Hg. Measurements were repeated at 60 and 120&#x000a0;min.</p><p>At the end of the experiment, animals were euthanized with an additional dose of pentobarbital and a potassium chloride bolus. A catheter was inserted in the superior mesenteric artery for the instillation of India ink. The dyed intestinal segments were dissected, washed, and weighed to calculate the gut indices. The left kidney was also weighed.</p></sec><sec id="Sec7"><title>Statistical analysis</title><p>Data were assessed for normality using the Shapiro-Wilk test and expressed as mean&#x02009;&#x000b1;&#x02009;SD. Two-way repeated measures analysis of variance (ANOVA) was used for comparison between the three groups. Pairwise comparisons between groups were performed with unpaired <italic>t</italic>-test with Bonferroni correction after a significant time X group interaction. The relationship between regional blood flow and abdominal perfusion pressure was evaluated with linear regression analysis. A <italic>P</italic> value &#x0003c;0.05 was considered to be significant.</p></sec></sec><sec id="Sec8" sec-type="results"><title>Results</title><sec id="Sec9"><title>Systemic effects</title><p>There were no differences in MAP at baseline and at 60&#x000a0;min among groups; but at 120&#x000a0;min, MAP was lower in the IAH control group compared to the others. APP decreased similarly in IAH control and IAH norepinephrine groups at 60&#x000a0;min. At 120&#x000a0;min, APP in IAH norepinephrine group increased to higher values than in IAH control group, but not different from the sham group. In IAH control and IAH norepinephrine groups, pulmonary and central venous pressures were higher than in the sham group. Cardiac index was similar throughout the experiment in the three groups (Table&#x000a0;<xref rid="Tab1" ref-type="table">1</xref> and Figure&#x000a0;<xref rid="Fig1" ref-type="fig">1</xref>). The dose of norepinephrine required to reach the target MAP was 0.23&#x02009;&#x000b1;&#x02009;0.10&#x000a0;&#x003bc;g.min<sup>&#x02212;1</sup>.kg<sup>&#x02212;1</sup>.<table-wrap id="Tab1"><label>Table 1</label><caption><p>
<bold>Systemic hemodynamics, oxygen transport, and acid-base variables</bold>
</p></caption><table frame="hsides" rules="groups"><thead><tr valign="top"><th/><th align="left"/><th align="left"/><th align="left" colspan="2">
<bold>Abdominal hypertension</bold>
</th></tr><tr valign="top"><th/><th align="left"/><th align="left">
<bold>Basal</bold>
</th><th align="left">
<bold>60&#x02032;</bold>
</th><th align="left">
<bold>120&#x02032;</bold>
</th></tr></thead><tbody><tr valign="top"><td rowspan="3">Mean arterial blood pressure (mm Hg)</td><td align="center">IAH control</td><td align="center">83&#x02009;&#x000b1;&#x02009;12</td><td align="center">75&#x02009;&#x000b1;&#x02009;10</td><td align="center">69&#x02009;&#x000b1;&#x02009;11*</td></tr><tr valign="top"><td align="center">IAH norepinephrine</td><td align="center">81&#x02009;&#x000b1;&#x02009;7</td><td align="center">73&#x02009;&#x000b1;&#x02009;9</td><td align="center">93&#x02009;&#x000b1;&#x02009;11</td></tr><tr valign="top"><td align="center">Sham</td><td align="center">76&#x02009;&#x000b1;&#x02009;13</td><td align="center">87&#x02009;&#x000b1;&#x02009;14</td><td align="center">87&#x02009;&#x000b1;&#x02009;15</td></tr><tr valign="top"><td rowspan="3">Heart rate (beats.min<sup>&#x02212;1</sup>)</td><td align="center">IAH control</td><td align="center">177&#x02009;&#x000b1;&#x02009;28</td><td align="center">183&#x02009;&#x000b1;&#x02009;51</td><td align="center">186&#x02009;&#x000b1;&#x02009;42</td></tr><tr valign="top"><td align="center">IAH norepinephrine</td><td align="center">173&#x02009;&#x000b1;&#x02009;26</td><td align="center">185&#x02009;&#x000b1;&#x02009;45</td><td align="center">209&#x02009;&#x000b1;&#x02009;43</td></tr><tr valign="top"><td align="center">Sham</td><td align="center">173&#x02009;&#x000b1;&#x02009;46</td><td align="center">174&#x02009;&#x000b1;&#x02009;38</td><td align="center">184&#x02009;&#x000b1;&#x02009;30</td></tr><tr valign="top"><td rowspan="3">Cardiac index (mL.min<sup>&#x02212;1</sup>.kg<sup>&#x02212;1</sup>)</td><td align="center">IAH control</td><td align="center">122&#x02009;&#x000b1;&#x02009;26</td><td align="center">121&#x02009;&#x000b1;&#x02009;41</td><td align="center">134&#x02009;&#x000b1;&#x02009;55</td></tr><tr valign="top"><td align="center">IAH norepinephrine</td><td align="center">96&#x02009;&#x000b1;&#x02009;17</td><td align="center">118&#x02009;&#x000b1;&#x02009;42</td><td align="center">113&#x02009;&#x000b1;&#x02009;37</td></tr><tr valign="top"><td align="center">Sham</td><td align="center">113&#x02009;&#x000b1;&#x02009;18</td><td align="center">120&#x02009;&#x000b1;&#x02009;28</td><td align="center">127&#x02009;&#x000b1;&#x02009;24</td></tr><tr valign="top"><td rowspan="3">Mean pulmonary pressure (mm Hg)</td><td align="center">IAH control</td><td align="center">16&#x02009;&#x000b1;&#x02009;4</td><td align="center">27&#x02009;&#x000b1;&#x02009;6</td><td align="center">27&#x02009;&#x000b1;&#x02009;4</td></tr><tr valign="top"><td align="center">IAH norepinephrine</td><td align="center">18&#x02009;&#x000b1;&#x02009;7</td><td align="center">34&#x02009;&#x000b1;&#x02009;11</td><td align="center">35&#x02009;&#x000b1;&#x02009;11</td></tr><tr valign="top"><td align="center">Sham</td><td align="center">16&#x02009;&#x000b1;&#x02009;3</td><td align="center">18&#x02009;&#x000b1;&#x02009;6*</td><td align="center">18&#x02009;&#x000b1;&#x02009;7*</td></tr><tr valign="top"><td rowspan="3">Pulmonary artery occlusion pressure (mm Hg)</td><td align="center">IAH control</td><td align="center">3&#x02009;&#x000b1;&#x02009;2</td><td align="center">8&#x02009;&#x000b1;&#x02009;4</td><td align="center">8&#x02009;&#x000b1;&#x02009;3</td></tr><tr valign="top"><td align="center">IAH norepinephrine</td><td align="center">4&#x02009;&#x000b1;&#x02009;2</td><td align="center">11&#x02009;&#x000b1;&#x02009;5</td><td align="center">14&#x02009;&#x000b1;&#x02009;6*</td></tr><tr valign="top"><td align="center">Sham</td><td align="center">4&#x02009;&#x000b1;&#x02009;2</td><td align="center">3&#x02009;&#x000b1;&#x02009;2*</td><td align="center">3&#x02009;&#x000b1;&#x02009;2*</td></tr><tr valign="top"><td rowspan="3">Central venous pressure (mm Hg)</td><td align="center">IAH control</td><td align="center">2&#x02009;&#x000b1;&#x02009;2</td><td align="center">7&#x02009;&#x000b1;&#x02009;3</td><td align="center">6&#x02009;&#x000b1;&#x02009;3</td></tr><tr valign="top"><td align="center">IAH norepinephrine</td><td align="center">2&#x02009;&#x000b1;&#x02009;2</td><td align="center">9&#x02009;&#x000b1;&#x02009;5</td><td align="center">11&#x02009;&#x000b1;&#x02009;6*</td></tr><tr valign="top"><td align="center">Sham</td><td align="center">2&#x02009;&#x000b1;&#x02009;1</td><td align="center">1&#x02009;&#x000b1;&#x02009;1*</td><td align="center">2&#x02009;&#x000b1;&#x02009;2*</td></tr><tr valign="top"><td rowspan="3">Systemic vascular resistance (dynes.s.cm<sup>&#x02212;5</sup>)</td><td align="center">IAH control</td><td align="center">3,071&#x02009;&#x000b1;&#x02009;459</td><td align="center">2,756&#x02009;&#x000b1;&#x02009;773</td><td align="center">2,236&#x02009;&#x000b1;&#x02009;481</td></tr><tr valign="top"><td align="center">IAH norepinephrine</td><td align="center">3,138&#x02009;&#x000b1;&#x02009;890</td><td align="center">2,433&#x02009;&#x000b1;&#x02009;1,481</td><td align="center">2,918&#x02009;&#x000b1;&#x02009;1,401</td></tr><tr valign="top"><td align="center">Sham</td><td align="center">2,579&#x02009;&#x000b1;&#x02009;714</td><td align="center">2,900&#x02009;&#x000b1;&#x02009;984</td><td align="center">2,674&#x02009;&#x000b1;&#x02009;935</td></tr><tr valign="top"><td rowspan="3">Pulmonary vascular resistance (dynes.s.cm<sup>&#x02212;5</sup>)</td><td align="center">IAH control</td><td align="center">523&#x02009;&#x000b1;&#x02009;195</td><td align="center">774&#x02009;&#x000b1;&#x02009;339</td><td align="center">682&#x02009;&#x000b1;&#x02009;251</td></tr><tr valign="top"><td align="center">IAH norepinephrine</td><td align="center">541&#x02009;&#x000b1;&#x02009;247</td><td align="center">872&#x02009;&#x000b1;&#x02009;661</td><td align="center">752&#x02009;&#x000b1;&#x02009;432</td></tr><tr valign="top"><td align="center">Sham</td><td align="center">435&#x02009;&#x000b1;&#x02009;199</td><td align="center">525&#x02009;&#x000b1;&#x02009;280</td><td align="center">471&#x02009;&#x000b1;&#x02009;267</td></tr><tr valign="top"><td rowspan="3">Systemic oxygen transport (mL.min<sup>&#x02212;1</sup>.kg<sup>&#x02212;1</sup>)</td><td align="center">IAH control</td><td align="center">13.4&#x02009;&#x000b1;&#x02009;3.1</td><td align="center">10.2&#x02009;&#x000b1;&#x02009;2.9</td><td align="center">10.7&#x02009;&#x000b1;&#x02009;4.6</td></tr><tr valign="top"><td align="center">IAH norepinephrine</td><td align="center">10.7&#x02009;&#x000b1;&#x02009;3.0</td><td align="center">8.4&#x02009;&#x000b1;&#x02009;3.7</td><td align="center">8.1&#x02009;&#x000b1;&#x02009;3.9</td></tr><tr valign="top"><td align="center">Sham</td><td align="center">11.2&#x02009;&#x000b1;&#x02009;3.7</td><td align="center">10.4&#x02009;&#x000b1;&#x02009;3.2</td><td align="center">10.9&#x02009;&#x000b1;&#x02009;3.1</td></tr><tr valign="top"><td rowspan="3">Systemic oxygen consumption (mL.min<sup>&#x02212;1</sup>.kg<sup>&#x02212;1</sup>)</td><td align="center">IAH control</td><td align="center">6.3&#x02009;&#x000b1;&#x02009;1.1</td><td align="center">6.0&#x02009;&#x000b1;&#x02009;1.2</td><td align="center">6.4&#x02009;&#x000b1;&#x02009;2.2</td></tr><tr valign="top"><td align="center">IAH norepinephrine</td><td align="center">5.3&#x02009;&#x000b1;&#x02009;1.3</td><td align="center">5.8&#x02009;&#x000b1;&#x02009;2.3</td><td align="center">4.7&#x02009;&#x000b1;&#x02009;2.0</td></tr><tr valign="top"><td align="center">Sham</td><td align="center">5.0&#x02009;&#x000b1;&#x02009;2.3</td><td align="center">5.1&#x02009;&#x000b1;&#x02009;2.3</td><td align="center">5.0&#x02009;&#x000b1;&#x02009;1.9</td></tr><tr valign="top"><td rowspan="3">Arterial pH</td><td align="center">IAH control</td><td align="center">7.39&#x02009;&#x000b1;&#x02009;0.07</td><td align="center">7.27&#x02009;&#x000b1;&#x02009;0.06</td><td align="center">7.20&#x02009;&#x000b1;&#x02009;0.09</td></tr><tr valign="top"><td align="center">IAH norepinephrine</td><td align="center">7.39&#x02009;&#x000b1;&#x02009;0.04</td><td align="center">7.22&#x02009;&#x000b1;&#x02009;0.08</td><td align="center">7.11&#x02009;&#x000b1;&#x02009;0.15</td></tr><tr valign="top"><td align="center">Sham</td><td align="center">7.40&#x02009;&#x000b1;&#x02009;0.06</td><td align="center">7.38&#x02009;&#x000b1;&#x02009;0.08*</td><td align="center">7.37&#x02009;&#x000b1;&#x02009;0.10*</td></tr><tr valign="top"><td rowspan="3">Arterial PCO<sub>2</sub> (mm Hg)</td><td align="center">IAH control</td><td align="center">35&#x02009;&#x000b1;&#x02009;3</td><td align="center">39&#x02009;&#x000b1;&#x02009;5</td><td align="center">40&#x02009;&#x000b1;&#x02009;6</td></tr><tr valign="top"><td align="center">IAH norepinephrine</td><td align="center">35&#x02009;&#x000b1;&#x02009;5</td><td align="center">42&#x02009;&#x000b1;&#x02009;3</td><td align="center">43&#x02009;&#x000b1;&#x02009;7</td></tr><tr valign="top"><td align="center">Sham</td><td align="center">37&#x02009;&#x000b1;&#x02009;4</td><td align="center">39&#x02009;&#x000b1;&#x02009;4</td><td align="center">38&#x02009;&#x000b1;&#x02009;3</td></tr><tr valign="top"><td rowspan="3">Arterial PO<sub>2</sub> (mm Hg)</td><td align="center">IAH control</td><td align="center">79&#x02009;&#x000b1;&#x02009;9</td><td align="center">58&#x02009;&#x000b1;&#x02009;13</td><td align="center">58&#x02009;&#x000b1;&#x02009;16</td></tr><tr valign="top"><td align="center">IAH norepinephrine</td><td align="center">76&#x02009;&#x000b1;&#x02009;9</td><td align="center">47&#x02009;&#x000b1;&#x02009;8</td><td align="center">55&#x02009;&#x000b1;&#x02009;8</td></tr><tr valign="top"><td align="center">Sham</td><td align="center">75&#x02009;&#x000b1;&#x02009;11</td><td align="center">67&#x02009;&#x000b1;&#x02009;18</td><td align="center">69&#x02009;&#x000b1;&#x02009;16</td></tr><tr valign="top"><td rowspan="3">Arterial base excess (mmol.L<sup>&#x02212;1</sup>)</td><td align="center">IAH control</td><td align="center">&#x02212;2&#x02009;&#x000b1;&#x02009;3</td><td align="center">&#x02212;9&#x02009;&#x000b1;&#x02009;3</td><td align="center">&#x02212;12&#x02009;&#x000b1;&#x02009;3</td></tr><tr valign="top"><td align="center">IAH norepinephrine</td><td align="center">&#x02212;3&#x02009;&#x000b1;&#x02009;4</td><td align="center">&#x02212;10&#x02009;&#x000b1;&#x02009;5</td><td align="center">&#x02212;15&#x02009;&#x000b1;&#x02009;7</td></tr><tr valign="top"><td align="center">Sham</td><td align="center">&#x02212;1&#x02009;&#x000b1;&#x02009;3</td><td align="center">&#x02212;2&#x02009;&#x000b1;&#x02009;4*</td><td align="center">&#x02212;3&#x02009;&#x000b1;&#x02009;5*</td></tr><tr valign="top"><td rowspan="3">Arterial anion gap (mmol.L<sup>&#x02212;1</sup>)</td><td align="center">IAH control</td><td align="center">12&#x02009;&#x000b1;&#x02009;3</td><td align="center">15&#x02009;&#x000b1;&#x02009;5</td><td align="center">17&#x02009;&#x000b1;&#x02009;6</td></tr><tr valign="top"><td align="center">IAH norepinephrine</td><td align="center">11&#x02009;&#x000b1;&#x02009;2</td><td align="center">14&#x02009;&#x000b1;&#x02009;4</td><td align="center">16&#x02009;&#x000b1;&#x02009;5</td></tr><tr valign="top"><td align="center">Sham</td><td align="center">9&#x02009;&#x000b1;&#x02009;3</td><td align="center">9&#x02009;&#x000b1;&#x02009;3*</td><td align="center">9&#x02009;&#x000b1;&#x02009;5*</td></tr><tr valign="top"><td rowspan="3">Arterial lactate (mmol.L<sup>&#x02212;1</sup>)</td><td align="center">IAH control</td><td align="center">1.9&#x02009;&#x000b1;&#x02009;0.7&#x000b1;</td><td align="center">4.0&#x02009;&#x000b1;&#x02009;2.5</td><td align="center">6.9&#x02009;&#x000b1;&#x02009;2.8</td></tr><tr valign="top"><td align="center">IAH norepinephrine</td><td align="center">2.2&#x02009;&#x000b1;&#x02009;0.5</td><td align="center">5.0&#x02009;&#x000b1;&#x02009;2.9</td><td align="center">6.9&#x02009;&#x000b1;&#x02009;1.8</td></tr><tr valign="top"><td align="center">Sham</td><td align="center">1.9&#x02009;&#x000b1;&#x02009;0.4</td><td align="center">1.3&#x02009;&#x000b1;&#x02009;0.6*</td><td align="center">2.6&#x02009;&#x000b1;&#x02009;0.6*</td></tr></tbody></table><table-wrap-foot><p>*<italic>P</italic> &#x0003c; 0.05 vs. the other groups.</p></table-wrap-foot></table-wrap><fig id="Fig1"><label>Figure 1</label><caption><p>
<bold>Changes in hemodynamics variables in IAH control, IAH norepinephrine and sham groups. (A)</bold> Abdominal perfusion pressure. <bold>(B)</bold> Percent of change in cardiac output. <bold>(C)</bold> Percent of change in superior mesenteric artery blood flow. <bold>(D)</bold> Percent of change in left renal artery blood flow.</p></caption><graphic xlink:href="40635_2015_46_Fig1_HTML" id="MO1"/></fig></p><p>In IAH control and IAH norepinephrine groups, there were comparable reductions of arterial pH and base excess, partially explained by the increase in the anion gap and in lactate concentration (Table&#x000a0;<xref rid="Tab1" ref-type="table">1</xref>). These groups required a larger volume of fluid administration to maintain cardiac output compared to the sham group (1,001&#x02009;&#x000b1;&#x02009;246, 938&#x02009;&#x000b1;&#x02009;170, and 376&#x02009;&#x000b1;&#x02009;105&#x000a0;mL, respectively, <italic>P</italic> &#x0003c; 0.0001).</p></sec><sec id="Sec10"><title>Effects on sublingual microcirculation</title><p>None of the sublingual microcirculatory variables changed over time (Additional file <xref rid="MOESM1" ref-type="media">1</xref>).</p></sec><sec id="Sec11"><title>Intestinal effects</title><p>Superior mesenteric artery blood flow (Figure&#x000a0;<xref rid="Fig1" ref-type="fig">1</xref> and Table&#x000a0;<xref rid="Tab2" ref-type="table">2</xref>), &#x00394;PCO<sub>2</sub> (Table&#x000a0;<xref rid="Tab2" ref-type="table">2</xref>), and each villi microvascular variable remained unchanged in the three groups (Additional file <xref rid="MOESM2" ref-type="media">2</xref>). We found no relationship between superior mesenteric artery blood flow and APP (Figure&#x000a0;<xref rid="Fig2" ref-type="fig">2</xref>).<table-wrap id="Tab2"><label>Table 2</label><caption><p>
<bold>Intestinal and renal hemodynamics, oxygen transport, and perfusion variables</bold>
</p></caption><table frame="hsides" rules="groups"><thead><tr valign="top"><th/><th align="left"/><th align="left"/><th align="left" colspan="2">
<bold>Abdominal hypertension</bold>
</th></tr><tr valign="top"><th/><th align="left"/><th align="left">
<bold>Basal</bold>
</th><th align="left">
<bold>60&#x02032;</bold>
</th><th align="left">
<bold>120&#x02032;</bold>
</th></tr></thead><tbody><tr valign="top"><td rowspan="3">Superior mesenteric artery blood flow (mL.min<sup>&#x02212;1</sup>.kg<sup>&#x02212;1</sup>)</td><td align="center">IAH control</td><td align="center">392&#x02009;&#x000b1;&#x02009;154</td><td align="center">524&#x02009;&#x000b1;&#x02009;302</td><td align="center">522&#x02009;&#x000b1;&#x02009;362</td></tr><tr valign="top"><td align="center">IAH norepinephrine</td><td align="center">445&#x02009;&#x000b1;&#x02009;318</td><td align="center">633&#x02009;&#x000b1;&#x02009;383</td><td align="center">634&#x02009;&#x000b1;&#x02009;401</td></tr><tr valign="top"><td align="center">Sham</td><td align="center">405&#x02009;&#x000b1;&#x02009;115</td><td align="center">449&#x02009;&#x000b1;&#x02009;88</td><td align="center">448&#x02009;&#x000b1;&#x02009;108</td></tr><tr valign="top"><td rowspan="3">Intestinal oxygen transport (mL.min<sup>&#x02212;1</sup>.kg<sup>&#x02212;1</sup>)</td><td align="center">IAH control</td><td align="center">45.2&#x02009;&#x000b1;&#x02009;16.5</td><td align="center">44.9&#x02009;&#x000b1;&#x02009;24.6</td><td align="center">43.5&#x02009;&#x000b1;&#x02009;30.9</td></tr><tr valign="top"><td align="center">IAH norepinephrine</td><td align="center">49.4&#x02009;&#x000b1;&#x02009;37.4</td><td align="center">44.6&#x02009;&#x000b1;&#x02009;32.7</td><td align="center">45.3&#x02009;&#x000b1;&#x02009;33.8</td></tr><tr valign="top"><td align="center">Sham</td><td align="center">38.6&#x02009;&#x000b1;&#x02009;9.6</td><td align="center">39.2&#x02009;&#x000b1;&#x02009;11.4</td><td align="center">37.8&#x02009;&#x000b1;&#x02009;10.7</td></tr><tr valign="top"><td rowspan="3">Intestinal oxygen consumption (mL.min<sup>&#x02212;1</sup>.kg<sup>&#x02212;1</sup>)</td><td align="center">IAH control</td><td align="center">16.9&#x02009;&#x000b1;&#x02009;5.1</td><td align="center">20.7&#x02009;&#x000b1;&#x02009;10.8</td><td align="center">15.8&#x02009;&#x000b1;&#x02009;11.0</td></tr><tr valign="top"><td align="center">IAH norepinephrine</td><td align="center">17.9&#x02009;&#x000b1;&#x02009;10.7</td><td align="center">23.5&#x02009;&#x000b1;&#x02009;13.4</td><td align="center">23.7&#x02009;&#x000b1;&#x02009;12.5</td></tr><tr valign="top"><td align="center">Sham</td><td align="center">14.8&#x02009;&#x000b1;&#x02009;5.9</td><td align="center">15.9&#x02009;&#x000b1;&#x02009;7.0</td><td align="center">15.8&#x02009;&#x000b1;&#x02009;6.3</td></tr><tr valign="top"><td rowspan="3">Intramucosal-arterial PCO<sub>2</sub> (mm Hg)</td><td align="center">IAH control</td><td align="center">7&#x02009;&#x000b1;&#x02009;6</td><td align="center">9&#x02009;&#x000b1;&#x02009;6</td><td align="center">8&#x02009;&#x000b1;&#x02009;5</td></tr><tr valign="top"><td align="center">IAH norepinephrine</td><td align="center">11&#x02009;&#x000b1;&#x02009;7</td><td align="center">12&#x02009;&#x000b1;&#x02009;5</td><td align="center">12&#x02009;&#x000b1;&#x02009;8</td></tr><tr valign="top"><td align="center">Sham</td><td align="center">4&#x02009;&#x000b1;&#x02009;4</td><td align="center">4&#x02009;&#x000b1;&#x02009;6</td><td align="center">3&#x02009;&#x000b1;&#x02009;5</td></tr><tr valign="top"><td rowspan="3">Renal filtration gradient (mm Hg)</td><td align="center">IAH control</td><td align="center">83&#x02009;&#x000b1;&#x02009;12</td><td align="center">35&#x02009;&#x000b1;&#x02009;5</td><td align="center">29&#x02009;&#x000b1;&#x02009;11</td></tr><tr valign="top"><td align="center">IAH norepinephrine</td><td align="center">81&#x02009;&#x000b1;&#x02009;7</td><td align="center">33&#x02009;&#x000b1;&#x02009;9</td><td align="center">53&#x02009;&#x000b1;&#x02009;11*</td></tr><tr valign="top"><td align="center">Sham</td><td align="center">76&#x02009;&#x000b1;&#x02009;13</td><td align="center">87&#x02009;&#x000b1;&#x02009;14*</td><td align="center">87&#x02009;&#x000b1;&#x02009;15*</td></tr><tr valign="top"><td rowspan="3">Renal blood flow (mL.min<sup>&#x02212;1</sup>.kg<sup>&#x02212;1</sup>)</td><td align="center">IAH control</td><td align="center">1,906&#x02009;&#x000b1;&#x02009;517</td><td align="center">943&#x02009;&#x000b1;&#x02009;416</td><td align="center">869&#x02009;&#x000b1;&#x02009;545</td></tr><tr valign="top"><td align="center">IAH norepinephrine</td><td align="center">1,905&#x02009;&#x000b1;&#x02009;729</td><td align="center">552&#x02009;&#x000b1;&#x02009;359</td><td align="center">620&#x02009;&#x000b1;&#x02009;317</td></tr><tr valign="top"><td align="center">Sham</td><td align="center">1,890&#x02009;&#x000b1;&#x02009;639</td><td align="center">1,729&#x02009;&#x000b1;&#x02009;510*</td><td align="center">1,678&#x02009;&#x000b1;&#x02009;569*</td></tr><tr valign="top"><td rowspan="3">Renal oxygen transport (mL.min<sup>&#x02212;1</sup>.kg<sup>&#x02212;1</sup>)</td><td align="center">IAH control</td><td align="center">222&#x02009;&#x000b1;&#x02009;64</td><td align="center">81&#x02009;&#x000b1;&#x02009;34</td><td align="center">75&#x02009;&#x000b1;&#x02009;43</td></tr><tr valign="top"><td align="center">IAH norepinephrine</td><td align="center">214&#x02009;&#x000b1;&#x02009;01</td><td align="center">38&#x02009;&#x000b1;&#x02009;28</td><td align="center">45&#x02009;&#x000b1;&#x02009;29</td></tr><tr valign="top"><td align="center">Sham</td><td align="center">183&#x02009;&#x000b1;&#x02009;58</td><td align="center">147&#x02009;&#x000b1;&#x02009;37*</td><td align="center">144&#x02009;&#x000b1;&#x02009;54*</td></tr><tr valign="top"><td rowspan="3">Urinary output (mL.h<sup>&#x02212;1</sup>.kg<sup>&#x02212;1</sup>)</td><td align="center">IAH control</td><td align="center">1.2&#x02009;&#x000b1;&#x02009;0.3</td><td align="center">0.4&#x02009;&#x000b1;&#x02009;0.1</td><td align="center">0.3&#x02009;&#x000b1;&#x02009;0.1</td></tr><tr valign="top"><td align="center">IAH norepinephrine</td><td align="center">1.1&#x02009;&#x000b1;&#x02009;0.5</td><td align="center">0.4&#x02009;&#x000b1;&#x02009;0.3</td><td align="center">0.2&#x02009;&#x000b1;&#x02009;0.1</td></tr><tr valign="top"><td align="center">Sham</td><td align="center">1.3&#x02009;&#x000b1;&#x02009;0.6</td><td align="center">0.9&#x02009;&#x000b1;&#x02009;0.5*</td><td align="center">1.0&#x02009;&#x000b1;&#x02009;0.6*</td></tr></tbody></table><table-wrap-foot><p>*<italic>P</italic>&#x02009;&#x0003c;&#x02009;0.05 vs. the other groups.</p></table-wrap-foot></table-wrap><fig id="Fig2"><label>Figure 2</label><caption><p>
<bold>Blood flow/perfusion pressure relationships. (A)</bold> Correlation between superior mesenteric artery blood flow and abdominal perfusion pressure. <bold>(B)</bold> Correlation between left renal artery blood flow and abdominal perfusion pressure.</p></caption><graphic xlink:href="40635_2015_46_Fig2_HTML" id="MO2"/></fig></p></sec><sec id="Sec12"><title>Renal effects</title><p>At 60 and 120&#x000a0;min of IAH, renal blood flow and urinary output were lower in IAH control and IAH norepinephrine groups, compared to the sham group (Figure&#x000a0;<xref rid="Fig1" ref-type="fig">1</xref> and Table&#x000a0;<xref rid="Tab2" ref-type="table">2</xref>). At 60&#x000a0;min, RFG decreased in IAH control and IAH norepinephrine groups, compared to the sham group. At 120&#x000a0;min, RFG increased in IAH norepinephrine group but remained lower than in the sham group. There were significant correlations between renal artery blood flow and APP (Figure 3) and between renal artery blood flow and urinary output (<italic>R</italic><sup>2</sup>&#x02009;=&#x02009;0.27, <italic>P</italic> &#x0003c; 0.0001). RFG was correlated with renal blood flow (<italic>R</italic><sup>2</sup>&#x02009;=&#x02009;0.39, <italic>P</italic> &#x0003c; 0.0001) and urinary output (<italic>R</italic><sup>2</sup>&#x02009;=&#x02009;0.31, <italic>P</italic> &#x0003c; 0.0001).</p></sec></sec><sec id="Sec13" sec-type="discussion"><title>Discussion</title><p>The main finding of this study was the contrasting effect of IAH on renal and gut physiology. Renal blood flow and urinary output experienced a sharp decrease while intestinal flow remained unaffected, even after the increase in MAP and APP produced by the infusion of norepinephrine.</p><p>In many experimental studies about IAH, it is difficult to ascertain whether hypoperfusion of intra-abdominal organs is a direct consequence of increased IAP, or just the result of low cardiac output, a well-known deleterious effect of IAH [<xref ref-type="bibr" rid="CR17">17</xref>,<xref ref-type="bibr" rid="CR18">18</xref>]. IAH may decrease cardiac output by different mechanisms, but the main cause is the reduction in cardiac filling, secondary to increased intrathoracic pressure and decreased venous return from the abdomen and lower limbs [<xref ref-type="bibr" rid="CR19">19</xref>]. In this model, cardiac output was kept constant by the infusion of fluids. In this way, we ruled out low cardiac output as the cause of intra-abdominal hypoperfusion. Although our study was not aimed at assessing the mechanisms of cardiac output reduction mediated by IAH, our sheep model showed that the increase in preload was able to preserve cardiac output. This finding highlights the relevance of avoiding hypovolemia in IAH.</p><p>Experimental research has shown controversial results about the gut involvement in IAH. Some studies describe reductions in mesenteric blood flow and mucosal microcirculation. Severe alterations in the villi microcirculation were reported with 15&#x000a0;mm Hg of IAP [<xref ref-type="bibr" rid="CR20">20</xref>]. Also, rabbits exposed to nitrogen pneumoperitoneum developed reduced mucosal blood flow and increased intestinal permeability, which resulted in endotoxin release to the systemic circulation, mitochondrial damage, and necrosis of the gut mucosa [<xref ref-type="bibr" rid="CR7">7</xref>]. Even though these studies warn about the catastrophic consequences of gut ischemia generated by IAH, it is not possible to ensure that the underlying mechanism is tissue hypoperfusion. Since cardiac output was not measured, it cannot be discarded that intestinal ischemia was the result of the compromise of systemic hemodynamics secondary to IAH, instead of increased IAP or reduced APP. Accordingly, in other studies, the changes in intestinal perfusion [<xref ref-type="bibr" rid="CR21">21</xref>] as all as in other organs were related to the changes in cardiac output, even when MAP and APP were only slightly reduced [<xref ref-type="bibr" rid="CR18">18</xref>]. An experimental model of intraperitoneal insufflation with CO<sub>2</sub> found only subtle reductions in microcirculatory flow in the small bowel mucosa [<xref ref-type="bibr" rid="CR22">22</xref>], which could be completely explained by decreases in cardiac output.</p><p>Accordingly, a main finding of our study, in which cardiac output was maintained stable, was the preservation of intestinal perfusion and oxygenation. We used a comprehensive approach for evaluation that included measurements of regional blood flow, oxygen transport and consumption, tissue PCO<sub>2</sub>, and videomicroscopy of the villi. After 2&#x000a0;h of an IAH of 20&#x000a0;mm Hg and a mean final APP lower than 50&#x000a0;mm Hg, all variable values were preserved. In addition, the superior mesenteric artery blood flow was not related to APP. This finding evidences the intestinal ability to autoregulate blood flow at lower driving pressures than other organs, such as the kidney. In line with our results, a previous animal study in which intestinal perfusion pressure was reduced by means of an adjustable clamp showed an ischemic threshold of only 33&#x000a0;mm Hg of MAP [<xref ref-type="bibr" rid="CR23">23</xref>]. Taking everything into account, we might speculate that in IAH, intestinal oxygenation and perfusion are preserved despite the fall in APP, because the intestine has a very low limit of flow autoregulation. The maintenance of cardiac output, however, seems to be required for such preservation.</p><p>We found that IAH was associated with severe reductions of renal blood flow and urinary output in face of a preserved cardiac output, implying a decrease in the fraction of cardiac output directed to the kidney. In contrast to intestinal blood flow, renal blood flow was linearly related to APP, suggesting a limited ability for autoregulation. Experimental studies also showed that impairments in renal blood flow and function were not corrected just by increasing cardiac output, suggesting that local phenomena might be responsible [<xref ref-type="bibr" rid="CR11">11</xref>,<xref ref-type="bibr" rid="CR24">24</xref>]. Conversely, other animal investigations showed a direct dependence of renal blood flow on cardiac output [<xref ref-type="bibr" rid="CR18">18</xref>,<xref ref-type="bibr" rid="CR25">25</xref>]. These discrepancies might be related to the different models of IAH.</p><p>Distinct processes may be responsible for the decrease in glomerular filtration and oliguria in IAH: from the reduction in cardiac output, renal blood flow, and APP to direct parenchymal, cava, renal vein, or ureteral compression and neurohumoral dysfunction [<xref ref-type="bibr" rid="CR3">3</xref>]. Although this study was not designed to explore these mechanisms, the significant correlation between urinary output and renal artery blood flow, APP, and renal filtration gradient suggests that the decreases in these variables induced by IAH were major determinants of oliguria.</p><p>In a previous study in bacteremic and non-bacteremic dogs with IAH, the restoration of APP with norepinephrine resulted in substantial but not complete reversal of the decreases in cardiac output and renal blood flow [<xref ref-type="bibr" rid="CR24">24</xref>]. In our study, the increase in MAP induced by norepinephrine was associated with significant improvements in APP and RFG compared to IAH control group. In spite of these potentially helpful effects, renal arterial blood flow and urinary output remained as low as in the IAH control group. Although these findings might indicate that the increase in driving pressure was not able to improve perfusion, the positive correlation between APP and renal blood flow suggests that increases &#x0003e;20&#x000a0;mm Hg in MAP and APP might be needed for such purpose. In addition, the RFG was improved but not normalized by norepinephrine. The renal filtration gradient is the fluid mechanical force across the glomerulus and is equal to the difference between glomerular filtration pressure and proximal tubular pressure. The decrease in RFG seems to be crucial to explain the renal impairment during IAH [<xref ref-type="bibr" rid="CR11">11</xref>]. Therefore, higher increases in blood pressure might have beneficial effects on renal physiology.</p><p>There is some concern about the potential detrimental effects of norepinephrine on tissue perfusion because of an excessive vasoconstriction. Indeed, septic patients with preserved sublingual microcirculation showed a detrimental response to increasing doses of norepinephrine [<xref ref-type="bibr" rid="CR26">26</xref>]. Despite this, we noticed no harmful effects of norepinephrine on a previously well-perfused villi microcirculation.</p><p>Notwithstanding the preservation of systemic and intestinal oxygen transport and villi and sublingual microcirculation, an anion gap metabolic acidosis and hyperlactatemia ensued. The ischemia of abdominal wall muscles could play a role in the development of these abnormalities. Studies using microdialysis showed that the increase in tissue lactate-to-pyruvate ratio, a marker of anaerobic metabolism, is more pronounced in the rectus abdominis muscle than in intra-abdominal organs [<xref ref-type="bibr" rid="CR27">27</xref>], though ischemia could have developed in territories not evaluated, such as stomach, colon, and seromuscular layer of the small intestine. In experimental IAH produced by intraperitoneal insufflation of CO<sub>2</sub>, small bowel mucosa was better preserved than the rest of microcirculatory gastrointestinal beds [<xref ref-type="bibr" rid="CR22">22</xref>]. Finally, a decrease in the clearance of lactate secondary to hepatic hypoperfusion might have contributed [<xref ref-type="bibr" rid="CR28">28</xref>].</p><p>This study has some limitations. While our model shared some characteristics with clinical conditions, IAH was not generated from capillary leakage and edema. Unfortunately, a more suitable experimental model has not yet been developed. Since only a single step in MAP and APP elevation was studied, we cannot rule out that additional increases in these variables induced by norepinephrine could further improve renal perfusion. Since larger volumes of a chloride-rich solution were infused in IAH groups, the load of chloride could play a role in the decrease of renal blood flow [<xref ref-type="bibr" rid="CR29">29</xref>]. Also, the administration of a starch solution could have produced deleterious effects on renal function [<xref ref-type="bibr" rid="CR30">30</xref>]<bold>.</bold> Other limitations are the short observation period, the lack of histology, and the small sample size. Finally, renal function was assessed only by means of urinary output. Experimental studies on IAH, however, have showed that this variable adequately tracks glomerular filtration [<xref ref-type="bibr" rid="CR18">18</xref>,<xref ref-type="bibr" rid="CR22">22</xref>].</p></sec><sec id="Sec14" sec-type="conclusions"><title>Conclusions</title><p>In this experimental model in which systemic hemodynamics was maintained by fluid resuscitation, an IAP of 20&#x000a0;mm Hg sustained for 2&#x000a0;h was associated with large decreases in renal blood flow and urinary output. In contrast, intestinal regional and microcirculatory blood flows were preserved. These findings suggest that the kidney and the gut have different autoregulatory thresholds. In addition, an increase of 20&#x000a0;mm Hg in MAP and APP induced by norepinephrine failed to improve kidney perfusion and function. Further studies are needed to define if larger increases in those variables might be useful.</p></sec></body><back><app-group><app id="App1"><sec id="Sec15"><title><bold>Additional files</bold></title><p><media position="anchor" xlink:href="40635_2015_46_MOESM1_ESM.pdf" id="MOESM1"><label>Additional file 1:</label><caption><p>
<bold>Changes in sublingual microcirculatory variables in IAH control, IAH norepinephrine, and sham groups.</bold>
</p></caption></media><media position="anchor" xlink:href="40635_2015_46_MOESM2_ESM.pdf" id="MOESM2"><label>Additional file 2:</label><caption><p>
<bold>Changes in intestinal villi microcirculatory variables in IAH control, IAH norepinephrine and sham groups.</bold>
<bold>(A)</bold> Total vascular density. <bold>(B)</bold> Perfused vascular density. <bold>(C)</bold> Proportion of perfused vessels. <bold>(D)</bold> Microvascular flow index. <bold>(E)</bold> Heterogeneity flow index.</p></caption></media></p></sec></app></app-group><glossary><title>Abbreviations</title><def-list><def-item><term>APP</term><def><p>abdominal perfusion pressure</p></def></def-item><def-item><term>DO<sub>2</sub></term><def><p>oxygen transport</p></def></def-item><def-item><term>IAH</term><def><p>intra-abdominal hypertension</p></def></def-item><def-item><term>IAP</term><def><p>intra-abdominal pressure</p></def></def-item><def-item><term>MAP</term><def><p>mean arterial pressure</p></def></def-item><def-item><term>MFI</term><def><p>microvascular flow index</p></def></def-item><def-item><term>RFG</term><def><p>renal filtration gradient</p></def></def-item><def-item><term>VO<sub>2</sub></term><def><p>oxygen consumption</p></def></def-item><def-item><term>&#x00394;PCO<sub>2</sub></term><def><p>intramucosal-arterial PCO<sub>2</sub></p></def></def-item></def-list></glossary><fn-group><fn><p>Gonzalo Ferrara and Vanina S Kanoore Edul contributed equally to this work.</p></fn><fn><p><bold>Competing interests</bold></p><p>Dr Ince has developed SDF imaging and is listed as inventor on related patents commercialized by MicroVision Medical (MVM) under a license from the Academic Medical Center (AMC). He has been a consultant for MVM in the past but has not been involved with this company for more than 5 years now, except that he still holds shares. Braedius Medical, a company owned by a relative of Dr Ince, has developed and designed a hand held microscope called CytoCam-IDF imaging. Dr Ince has no financial relation with Braedius Medical of any sort, i.e., never owned shares, or received consultancy or speaker fees from Braedius Medical. All other authors declare that they have no competing interests.</p></fn><fn><p><bold>Authors&#x02019; contributions</bold></p><p>GF, VSKE, JFCE, EM, CC, HSC, and AD carried out the animal experiments and participated in the design of the study. AD performed the statistical analyses and drafted the manuscript. CI and EE participated in the study design and interpretation of the data. All authors discussed the results and participated in the writing of the manuscript. All authors read and approved the final manuscript.</p></fn></fn-group><ack><title>Acknowledgements</title><p>This work was supported by the grant PICT-2010-0495, Agencia Nacional de Promoci&#x000f3;n Cient&#x000ed;fica y Tecnol&#x000f3;gica, Argentina.</p></ack><ref-list id="Bib1"><title>References</title><ref id="CR1"><label>1.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Malbrain</surname><given-names>ML</given-names></name><name><surname>Chiumello</surname><given-names>D</given-names></name><name><surname>Cesana</surname><given-names>BM</given-names></name><name><surname>Reintam Blaser</surname><given-names>A</given-names></name><name><surname>Starkopf</surname><given-names>J</given-names></name><name><surname>Sugrue</surname><given-names>M</given-names></name><name><surname>Pelosi</surname><given-names>P</given-names></name><name><surname>Severgnini</surname><given-names>P</given-names></name><name><surname>Hernandez</surname><given-names>G</given-names></name><name><surname>Brienza</surname><given-names>N</given-names></name><name><surname>Kirkpatrick</surname><given-names>AW</given-names></name><name><surname>Schachtrupp</surname><given-names>A</given-names></name><name><surname>Kempchen</surname><given-names>J</given-names></name><name><surname>Estenssoro</surname><given-names>E</given-names></name><name><surname>Vidal</surname><given-names>MG</given-names></name><name><surname>De Laet</surname><given-names>I</given-names></name><name><surname>De Keulenaer</surname><given-names>BL</given-names></name><collab>WAKE-Up! Investigators</collab></person-group><article-title>A systematic review and individual patient data meta-analysis on intra-abdominal hypertension in critically ill patients: the wake-up project. World initiative on Abdominal Hypertension Epidemiology, a Unifying Project (WAKE-Up!)</article-title><source>Minerva Anestesiol</source><year>2014</year><volume>80</volume><fpage>293</fpage><lpage>306</lpage><pub-id pub-id-type="pmid">24603146</pub-id></element-citation></ref><ref id="CR2"><label>2.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Malbrain</surname><given-names>ML</given-names></name><name><surname>Cheatham</surname><given-names>ML</given-names></name><name><surname>Kirkpatrick</surname><given-names>A</given-names></name><name><surname>Sugrue</surname><given-names>M</given-names></name><name><surname>Parr</surname><given-names>M</given-names></name><name><surname>De Waele</surname><given-names>J</given-names></name><name><surname>Balogh</surname><given-names>Z</given-names></name><name><surname>Lepp&#x000e4;niemi</surname><given-names>A</given-names></name><name><surname>Olvera</surname><given-names>C</given-names></name><name><surname>Ivatury</surname><given-names>R</given-names></name><name><surname>D&#x02019;Amours</surname><given-names>S</given-names></name><name><surname>Wendon</surname><given-names>J</given-names></name><name><surname>Hillman</surname><given-names>K</given-names></name><name><surname>Johansson</surname><given-names>K</given-names></name><name><surname>Kolkman</surname><given-names>K</given-names></name><name><surname>Wilmer</surname><given-names>A</given-names></name></person-group><article-title>Results from the International Conference of Experts on Intra-abdominal Hypertension and Abdominal Compartment Syndrome. I. Definitions</article-title><source>Intensive Care Med</source><year>2006</year><volume>32</volume><fpage>1722</fpage><lpage>1732</lpage><pub-id pub-id-type="doi">10.1007/s00134-006-0349-5</pub-id><pub-id pub-id-type="pmid">16967294</pub-id></element-citation></ref><ref id="CR3"><label>3.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mohmand</surname><given-names>H</given-names></name><name><surname>Goldfarb</surname><given-names>S</given-names></name></person-group><article-title>Renal dysfunction associated with intra-abdominal hypertension and the abdominal compartment syndrome</article-title><source>J Am Soc Nephrol</source><year>2011</year><volume>22</volume><fpage>615</fpage><lpage>621</lpage><pub-id pub-id-type="doi">10.1681/ASN.2010121222</pub-id><pub-id pub-id-type="pmid">21310818</pub-id></element-citation></ref><ref id="CR4"><label>4.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Leduc</surname><given-names>LJ</given-names></name><name><surname>Mitchell</surname><given-names>A</given-names></name></person-group><article-title>Intestinal ischemia after laparoscopic cholecystectomy</article-title><source>JSLS</source><year>2006</year><volume>10</volume><fpage>236</fpage><lpage>238</lpage><pub-id pub-id-type="pmid">16882427</pub-id></element-citation></ref><ref id="CR5"><label>5.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Al-Bahrani</surname><given-names>AZ</given-names></name><name><surname>Darwish</surname><given-names>A</given-names></name><name><surname>Hamza</surname><given-names>N</given-names></name><name><surname>Benson</surname><given-names>J</given-names></name><name><surname>Eddleston</surname><given-names>JM</given-names></name><name><surname>Snider</surname><given-names>RH</given-names></name><name><surname>Nyl&#x000e9;n</surname><given-names>ES</given-names></name><name><surname>Becker</surname><given-names>KL</given-names></name><name><surname>Barclay</surname><given-names>GR</given-names></name><name><surname>Ammori</surname><given-names>BJ</given-names></name></person-group><article-title>Gut barrier dysfunction in critically ill surgical patients with abdominal compartment syndrome</article-title><source>Pancreas</source><year>2010</year><volume>39</volume><fpage>1064</fpage><lpage>1069</lpage><pub-id pub-id-type="doi">10.1097/MPA.0b013e3181da8d51</pub-id><pub-id pub-id-type="pmid">20861696</pub-id></element-citation></ref><ref id="CR6"><label>6.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Djavani</surname><given-names>K</given-names></name><name><surname>Wanhainen</surname><given-names>A</given-names></name><name><surname>Valtysson</surname><given-names>J</given-names></name><name><surname>Bj&#x000f6;rck</surname><given-names>M</given-names></name></person-group><article-title>Colonic ischaemia and intra-abdominal hypertension following open repair of ruptured abdominal aortic aneurysm</article-title><source>Br J Surg</source><year>2009</year><volume>96</volume><fpage>621</fpage><lpage>627</lpage><pub-id pub-id-type="doi">10.1002/bjs.6592</pub-id><pub-id pub-id-type="pmid">19384909</pub-id></element-citation></ref><ref id="CR7"><label>7.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cheng</surname><given-names>J</given-names></name><name><surname>Wei</surname><given-names>Z</given-names></name><name><surname>Liu</surname><given-names>X</given-names></name><name><surname>Li</surname><given-names>X</given-names></name><name><surname>Yuan</surname><given-names>Z</given-names></name><name><surname>Zheng</surname><given-names>J</given-names></name><name><surname>Chen</surname><given-names>X</given-names></name><name><surname>Xiao</surname><given-names>G</given-names></name><name><surname>Li</surname><given-names>X</given-names></name></person-group><article-title>The role of intestinal mucosa injury induced by intra-abdominal hypertension in the development of abdominal compartment syndrome and multiple organ dysfunction syndrome</article-title><source>Crit Care</source><year>2013</year><volume>17</volume><fpage>R283</fpage><pub-id pub-id-type="doi">10.1186/cc13146</pub-id><pub-id pub-id-type="pmid">24321230</pub-id></element-citation></ref><ref id="CR8"><label>8.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gudmundsson</surname><given-names>FF</given-names></name><name><surname>Gislason</surname><given-names>HG</given-names></name><name><surname>Dicko</surname><given-names>A</given-names></name><name><surname>Horn</surname><given-names>A</given-names></name><name><surname>Viste</surname><given-names>A</given-names></name><name><surname>Grong</surname><given-names>K</given-names></name><name><surname>Svanes</surname><given-names>K</given-names></name></person-group><article-title>Effects of prolonged increased intra-abdominal pressure on gastrointestinal blood flow in pigs</article-title><source>Surg Endosc</source><year>2001</year><volume>15</volume><fpage>854</fpage><lpage>856</lpage><pub-id pub-id-type="doi">10.1007/s004640090090</pub-id><pub-id pub-id-type="pmid">11443466</pub-id></element-citation></ref><ref id="CR9"><label>9.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cheatham</surname><given-names>ML</given-names></name><name><surname>White</surname><given-names>MW</given-names></name><name><surname>Sagraves</surname><given-names>SG</given-names></name><name><surname>Johnson</surname><given-names>JL</given-names></name><name><surname>Block</surname><given-names>EF</given-names></name></person-group><article-title>Abdominal perfusion pressure: a superior parameter in the assessment of intra-abdominal hypertension</article-title><source>J Trauma</source><year>2000</year><volume>49</volume><fpage>621</fpage><lpage>626</lpage><pub-id pub-id-type="doi">10.1097/00005373-200010000-00008</pub-id><pub-id pub-id-type="pmid">11038078</pub-id></element-citation></ref><ref id="CR10"><label>10.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kirkpatrick</surname><given-names>AW</given-names></name><name><surname>Roberts</surname><given-names>DJ</given-names></name><name><surname>De Waele</surname><given-names>J</given-names></name><name><surname>Jaeschke</surname><given-names>R</given-names></name><name><surname>Malbrain</surname><given-names>ML</given-names></name><name><surname>De Keulenaer</surname><given-names>B</given-names></name><name><surname>Duchesne</surname><given-names>J</given-names></name><name><surname>Bjorck</surname><given-names>M</given-names></name><name><surname>Leppaniemi</surname><given-names>A</given-names></name><name><surname>Ejike</surname><given-names>JC</given-names></name><name><surname>Sugrue</surname><given-names>M</given-names></name><name><surname>Cheatham</surname><given-names>M</given-names></name><name><surname>Ivatury</surname><given-names>R</given-names></name><name><surname>Ball</surname><given-names>CG</given-names></name><name><surname>Reintam Blaser</surname><given-names>A</given-names></name><name><surname>Regli</surname><given-names>A</given-names></name><name><surname>Balogh</surname><given-names>ZJ</given-names></name><name><surname>D&#x02019;Amours</surname><given-names>S</given-names></name><name><surname>Debergh</surname><given-names>D</given-names></name><name><surname>Kaplan</surname><given-names>M</given-names></name><name><surname>Kimball</surname><given-names>E</given-names></name><name><surname>Olvera</surname><given-names>C</given-names></name><collab>Pediatric Guidelines Sub-Committee for the World Society of the Abdominal Compartment Syndrome</collab></person-group><article-title>Intra-abdominal hypertension and the abdominal compartment syndrome: updated consensus definitions and clinical practice guidelines from the World Society of the Abdominal Compartment Syndrome</article-title><source>Intensive Care Med</source><year>2013</year><volume>39</volume><fpage>1190</fpage><lpage>1206</lpage><pub-id pub-id-type="doi">10.1007/s00134-013-2906-z</pub-id><pub-id pub-id-type="pmid">23673399</pub-id></element-citation></ref><ref id="CR11"><label>11.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wauters</surname><given-names>J</given-names></name><name><surname>Claus</surname><given-names>P</given-names></name><name><surname>Brosens</surname><given-names>N</given-names></name><name><surname>McLaughlin</surname><given-names>M</given-names></name><name><surname>Malbrain</surname><given-names>M</given-names></name><name><surname>Wilmer</surname><given-names>A</given-names></name></person-group><article-title>Pathophysiology of renal hemodynamics and renal cortical microcirculation in a porcine model of elevated intra-abdominal pressure</article-title><source>J Trauma</source><year>2009</year><volume>66</volume><fpage>713</fpage><lpage>719</lpage><pub-id pub-id-type="doi">10.1097/TA.0b013e31817c5594</pub-id><pub-id pub-id-type="pmid">19276743</pub-id></element-citation></ref><ref id="CR12"><label>12.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Goedhart</surname><given-names>PT</given-names></name><name><surname>Khalilzada</surname><given-names>M</given-names></name><name><surname>Bezemer</surname><given-names>R</given-names></name><name><surname>Merza</surname><given-names>J</given-names></name><name><surname>Ince</surname><given-names>C</given-names></name></person-group><article-title>Sidestream dark field (SDF) imaging: a novel stroboscopic LED ring-based imaging modality for clinical assessment of the microcirculation</article-title><source>Opt Express</source><year>2007</year><volume>15</volume><fpage>15101</fpage><lpage>15114</lpage><pub-id pub-id-type="doi">10.1364/OE.15.015101</pub-id><pub-id pub-id-type="pmid">19550794</pub-id></element-citation></ref><ref id="CR13"><label>13.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pozo</surname><given-names>MO</given-names></name><name><surname>Kanoore Edul</surname><given-names>VS</given-names></name><name><surname>Ince</surname><given-names>C</given-names></name><name><surname>Dubin</surname><given-names>A</given-names></name></person-group><article-title>Comparison of different methods for the calculation of the microvascular flow index</article-title><source>Crit Care Res Pract</source><year>2012</year><volume>2012</volume><fpage>102483</fpage><pub-id pub-id-type="pmid">22593824</pub-id></element-citation></ref><ref id="CR14"><label>14.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dobbe</surname><given-names>JG</given-names></name><name><surname>Streekstra</surname><given-names>GJ</given-names></name><name><surname>Atasever</surname><given-names>B</given-names></name><name><surname>van Zijderveld</surname><given-names>R</given-names></name><name><surname>Ince</surname><given-names>C</given-names></name></person-group><article-title>Measurement of functional microcirculatory geometry and velocity distributions using automated image analysis</article-title><source>Med Biol Eng Comput</source><year>2008</year><volume>46</volume><fpage>659</fpage><lpage>670</lpage><pub-id pub-id-type="doi">10.1007/s11517-008-0349-4</pub-id><pub-id pub-id-type="pmid">18427850</pub-id></element-citation></ref><ref id="CR15"><label>15.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Trzeciak</surname><given-names>S</given-names></name><name><surname>Dellinger</surname><given-names>RP</given-names></name><name><surname>Parrillo</surname><given-names>JE</given-names></name><name><surname>Guglielmi</surname><given-names>M</given-names></name><name><surname>Bajaj</surname><given-names>J</given-names></name><name><surname>Abate</surname><given-names>NL</given-names></name><name><surname>Arnold</surname><given-names>RC</given-names></name><name><surname>Colilla</surname><given-names>S</given-names></name><name><surname>Zanotti</surname><given-names>S</given-names></name><name><surname>Hollenberg</surname><given-names>SM</given-names></name><collab>Microcirculatory Alterations in Resuscitation and Shock Investigators</collab></person-group><article-title>Early microcirculatory perfusion derangements in patients with severe sepsis and septic shock: relationship to hemodynamics, oxygen transport, and survival</article-title><source>Ann Emerg Med</source><year>2007</year><volume>49</volume><fpage>88</fpage><lpage>98</lpage><pub-id pub-id-type="doi">10.1016/j.annemergmed.2006.08.021</pub-id><pub-id pub-id-type="pmid">17095120</pub-id></element-citation></ref><ref id="CR16"><label>16.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dubin</surname><given-names>A</given-names></name><name><surname>Pozo</surname><given-names>MO</given-names></name><name><surname>Ferrara</surname><given-names>G</given-names></name><name><surname>Murias</surname><given-names>G</given-names></name><name><surname>Martins</surname><given-names>E</given-names></name><name><surname>Canull&#x000e1;n</surname><given-names>C</given-names></name><name><surname>Canales</surname><given-names>HS</given-names></name><name><surname>Kanoore Edul</surname><given-names>VS</given-names></name><name><surname>Estenssoro</surname><given-names>E</given-names></name><name><surname>Ince</surname><given-names>C</given-names></name></person-group><article-title>Systemic and microcirculatory responses to progressive hemorrhage</article-title><source>Intensive Care Med</source><year>2009</year><volume>35</volume><fpage>556</fpage><lpage>564</lpage><pub-id pub-id-type="doi">10.1007/s00134-008-1385-0</pub-id><pub-id pub-id-type="pmid">19127356</pub-id></element-citation></ref><ref id="CR17"><label>17.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Barnes</surname><given-names>GE</given-names></name><name><surname>Laine</surname><given-names>GA</given-names></name><name><surname>Giam</surname><given-names>PY</given-names></name><name><surname>Smith</surname><given-names>EE</given-names></name><name><surname>Granger</surname><given-names>HJ</given-names></name></person-group><article-title>Cardiovascular responses to elevation of intra-abdominal hydrostatic pressure</article-title><source>Am J Physiol</source><year>1985</year><volume>248</volume><issue>2 Pt 2</issue><fpage>R208</fpage><lpage>R213</lpage><pub-id pub-id-type="pmid">3918464</pub-id></element-citation></ref><ref id="CR18"><label>18.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lindstr&#x000f6;m</surname><given-names>P</given-names></name><name><surname>K&#x000e4;llskog</surname><given-names>O</given-names></name><name><surname>Wadstr&#x000f6;m</surname><given-names>J</given-names></name><name><surname>Persson</surname><given-names>AE</given-names></name></person-group><article-title>Blood flow distribution during elevated intraperitoneal pressure in the rat</article-title><source>Acta Physiol Scand</source><year>2003</year><volume>177</volume><fpage>149</fpage><lpage>156</lpage><pub-id pub-id-type="doi">10.1046/j.1365-201X.2003.01056.x</pub-id><pub-id pub-id-type="pmid">12558551</pub-id></element-citation></ref><ref id="CR19"><label>19.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Takata</surname><given-names>M</given-names></name><name><surname>Wise</surname><given-names>RA</given-names></name><name><surname>Robotham</surname><given-names>JL</given-names></name></person-group><article-title>Effects of abdominal pressure on venous return: abdominal vascular zone conditions</article-title><source>J Appl Physiol</source><year>1990</year><volume>69</volume><fpage>1961</fpage><lpage>1972</lpage><pub-id pub-id-type="pmid">2076989</pub-id></element-citation></ref><ref id="CR20"><label>20.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Samel</surname><given-names>ST</given-names></name><name><surname>Neufang</surname><given-names>T</given-names></name><name><surname>Mueller</surname><given-names>A</given-names></name><name><surname>Leister</surname><given-names>I</given-names></name><name><surname>Becker</surname><given-names>H</given-names></name><name><surname>Post</surname><given-names>S</given-names></name></person-group><article-title>A new abdominal cavity chamber to study the impact of increased intra-abdominal pressure on microcirculation of gut mucosa by using video microscopy in rats</article-title><source>Crit Care Med</source><year>2002</year><volume>30</volume><fpage>1854</fpage><lpage>1858</lpage><pub-id pub-id-type="doi">10.1097/00003246-200208000-00030</pub-id><pub-id pub-id-type="pmid">12163805</pub-id></element-citation></ref><ref id="CR21"><label>21.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Agust&#x000ed;</surname><given-names>M</given-names></name><name><surname>Elizalde</surname><given-names>JI</given-names></name><name><surname>Ad&#x000e0;lia</surname><given-names>R</given-names></name><name><surname>Cifuentes</surname><given-names>A</given-names></name><name><surname>Fontanals</surname><given-names>J</given-names></name><name><surname>Taur&#x000e0;</surname><given-names>P</given-names></name></person-group><article-title>Dobutamine restores intestinal mucosal blood flow in a porcine model of intra-abdominal hyperpressure</article-title><source>Crit Care Med</source><year>2000</year><volume>28</volume><fpage>467</fpage><lpage>472</lpage><pub-id pub-id-type="doi">10.1097/00003246-200002000-00030</pub-id><pub-id pub-id-type="pmid">10708185</pub-id></element-citation></ref><ref id="CR22"><label>22.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Olofsson</surname><given-names>PH</given-names></name><name><surname>Berg</surname><given-names>S</given-names></name><name><surname>Ahn</surname><given-names>HC</given-names></name><name><surname>Brudin</surname><given-names>LH</given-names></name><name><surname>Vikstr&#x000f6;m</surname><given-names>T</given-names></name><name><surname>Johansson</surname><given-names>KJ</given-names></name></person-group><article-title>Gastrointestinal microcirculation and cardiopulmonary function during experimentally increased intra-abdominal pressure</article-title><source>Crit Care Med</source><year>2009</year><volume>37</volume><fpage>230</fpage><lpage>239</lpage><pub-id pub-id-type="doi">10.1097/CCM.0b013e318192ff51</pub-id><pub-id pub-id-type="pmid">19050608</pub-id></element-citation></ref><ref id="CR23"><label>23.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lehtipalo</surname><given-names>S</given-names></name><name><surname>Biber</surname><given-names>B</given-names></name><name><surname>Fr&#x000f6;jse</surname><given-names>R</given-names></name><name><surname>Arnerl&#x000f6;v</surname><given-names>C</given-names></name><name><surname>Johansson</surname><given-names>G</given-names></name><name><surname>Wins&#x000f6;</surname><given-names>O</given-names></name></person-group><article-title>Effects of dopexamine and positive end-expiratory pressure on intestinal blood flow and oxygenation: the perfusion pressure perspective</article-title><source>Chest</source><year>2003</year><volume>124</volume><fpage>688</fpage><lpage>698</lpage><pub-id pub-id-type="doi">10.1378/chest.124.2.688</pub-id><pub-id pub-id-type="pmid">12907561</pub-id></element-citation></ref><ref id="CR24"><label>24.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Harman</surname><given-names>PK</given-names></name><name><surname>Kron</surname><given-names>IL</given-names></name><name><surname>McLachlan</surname><given-names>HD</given-names></name><name><surname>Freedlender</surname><given-names>AE</given-names></name><name><surname>Nolan</surname><given-names>SP</given-names></name></person-group><article-title>Elevated intra-abdominal pressure and renal function</article-title><source>Ann Surg</source><year>1982</year><volume>196</volume><fpage>594</fpage><lpage>597</lpage><pub-id pub-id-type="doi">10.1097/00000658-198211000-00015</pub-id><pub-id pub-id-type="pmid">7125746</pub-id></element-citation></ref><ref id="CR25"><label>25.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Peng</surname><given-names>ZY</given-names></name><name><surname>Critchley</surname><given-names>LA</given-names></name><name><surname>Joynt</surname><given-names>GM</given-names></name><name><surname>Gruber</surname><given-names>PC</given-names></name><name><surname>Jenkins</surname><given-names>CR</given-names></name><name><surname>Ho</surname><given-names>AM</given-names></name></person-group><article-title>Effects of norepinephrine during intra-abdominal hypertension on renal blood flow in bacteremic dogs</article-title><source>Crit Care Med</source><year>2008</year><volume>36</volume><fpage>834</fpage><lpage>841</lpage><pub-id pub-id-type="doi">10.1097/CCM.0B013E31816439FB</pub-id><pub-id pub-id-type="pmid">18209675</pub-id></element-citation></ref><ref id="CR26"><label>26.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dubin</surname><given-names>A</given-names></name><name><surname>Pozo</surname><given-names>MO</given-names></name><name><surname>Casabella</surname><given-names>CA</given-names></name><name><surname>P&#x000e1;lizas</surname><given-names>F</given-names><suffix>Jr</suffix></name><name><surname>Murias</surname><given-names>G</given-names></name><name><surname>Moseinco</surname><given-names>MC</given-names></name><name><surname>Kanoore Edul</surname><given-names>VS</given-names></name><name><surname>P&#x000e1;lizas</surname><given-names>F</given-names></name><name><surname>Estenssoro</surname><given-names>E</given-names></name><name><surname>Ince</surname><given-names>C</given-names></name></person-group><article-title>Increasing arterial blood pressure with norepinephrine does not improve microcirculatory blood flow: a prospective study</article-title><source>Crit Care</source><year>2009</year><volume>13</volume><fpage>R92</fpage><pub-id pub-id-type="doi">10.1186/cc7922</pub-id><pub-id pub-id-type="pmid">19534818</pub-id></element-citation></ref><ref id="CR27"><label>27.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Meier</surname><given-names>C</given-names></name><name><surname>Contaldo</surname><given-names>C</given-names></name><name><surname>Schramm</surname><given-names>R</given-names></name><name><surname>Holstein</surname><given-names>JH</given-names></name><name><surname>Hamacher</surname><given-names>J</given-names></name><name><surname>Amon</surname><given-names>M</given-names></name><name><surname>Wanner</surname><given-names>GA</given-names></name><name><surname>Trentz</surname><given-names>O</given-names></name><name><surname>Menger</surname><given-names>MD</given-names></name></person-group><article-title>Microdialysis of the rectus abdominis muscle for early detection of impending abdominal compartment syndrome</article-title><source>Intensive Care Med</source><year>2007</year><volume>33</volume><fpage>1434</fpage><lpage>1443</lpage><pub-id pub-id-type="doi">10.1007/s00134-007-0725-9</pub-id><pub-id pub-id-type="pmid">17576536</pub-id></element-citation></ref><ref id="CR28"><label>28.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Malbrain</surname><given-names>ML</given-names></name><name><surname>Viaene</surname><given-names>D</given-names></name><name><surname>Kortgen</surname><given-names>A</given-names></name><name><surname>De Laet</surname><given-names>I</given-names></name><name><surname>Dits</surname><given-names>H</given-names></name><name><surname>Van Regenmortel</surname><given-names>N</given-names></name><name><surname>Schoonheydt</surname><given-names>K</given-names></name><name><surname>Bauer</surname><given-names>M</given-names></name></person-group><article-title>Relationship between intra-abdominal pressure and indocyanine green plasma disappearance rate: hepatic perfusion may be impaired in critically ill patients with intra-abdominal hypertension</article-title><source>Ann Intensive Care</source><year>2012</year><volume>2 Suppl 1</volume><fpage>S19</fpage><pub-id pub-id-type="doi">10.1186/2110-5820-2-S1-S19</pub-id><pub-id pub-id-type="pmid">23282242</pub-id></element-citation></ref><ref id="CR29"><label>29.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wilcox</surname><given-names>CS</given-names></name></person-group><article-title>Regulation of renal blood flow by plasma chloride</article-title><source>J Clin Invest</source><year>1983</year><volume>71</volume><fpage>726</fpage><lpage>735</lpage><pub-id pub-id-type="doi">10.1172/JCI110820</pub-id><pub-id pub-id-type="pmid">6826732</pub-id></element-citation></ref><ref id="CR30"><label>30.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Myburgh</surname><given-names>JA</given-names></name><name><surname>Finfer</surname><given-names>S</given-names></name><name><surname>Bellomo</surname><given-names>R</given-names></name><name><surname>Billot</surname><given-names>L</given-names></name><name><surname>Cass</surname><given-names>A</given-names></name><name><surname>Gattas</surname><given-names>D</given-names></name><name><surname>Glass</surname><given-names>P</given-names></name><name><surname>Lipman</surname><given-names>J</given-names></name><name><surname>Liu</surname><given-names>B</given-names></name><name><surname>McArthur</surname><given-names>C</given-names></name><name><surname>McGuinness</surname><given-names>S</given-names></name><name><surname>Rajbhandari</surname><given-names>D</given-names></name><name><surname>Taylor</surname><given-names>CB</given-names></name><name><surname>Webb</surname><given-names>SA</given-names></name><collab>CHEST Investigators; Australian and New Zealand Intensive Care Society Clinical Trials Group</collab></person-group><article-title>Hydroxyethyl starch or saline for fluid resuscitation in intensive care</article-title><source>N Engl J Med</source><year>2012</year><volume>367</volume><fpage>1901</fpage><lpage>1911</lpage><pub-id pub-id-type="doi">10.1056/NEJMoa1209759</pub-id><pub-id pub-id-type="pmid">23075127</pub-id></element-citation></ref></ref-list></back></article>